• Optomeditech has successfully secured ISO 13485 certificate of Quality Management System and has obtained CE mark approval for its OptiVein System to aid in IV cannulation.

    These are two important milestones for Optomeditech which support our mission to provide value creating innovative solutions in healthcare to simplify, ease and protect the life and well being of patients and caregivers.


    It also gives us the ability to start validating the results of OptiVein system through clinical trials that will demonstrate the safety and efficiency of the system as well as proof successful venous access after first attempt.


    These key clinical data will eventually support the launch of our product on the European market and contribute significantly to its commercialization.